Clinical Trial Update: Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating bilastine's effect on F1 simulator driving performance in patients with allergic rhinitis and/or urticaria. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• Bilastine (bilastine)

Snippet

Sponsor: Menarini International Operations Luxembourg SA | Conditions: Allergic Rhinitis, Urticaria | Phase 4 | Status: COMPLETED | Results posted: 2017-01-16